It would be interesting in future studies to investigate whether there is any change to S1P levels in the cerebrospinal fluid (CSF) of subjects with mild cognitive impairment or AD; and whether S1P levels in the CSF vary with APOE genotype. The gene discussed is APOE; the disease is Alzheimer disease.